The Autoimmunity-Associated Gene PTPN22 Potentiates Toll-like Receptor-Driven, Type 1 Interferon-Dependent Immunity

Yaya Wang; Iftach Shaked; StephanieM Stanford; Wenbo Zhou; JulieM Curtsinger; Zbigniew Mikulski; ZacharyR Shaheen; Genhong Cheng; Kristy Sawatzke; AmandaM Campbell; JenniferL Auger; Hatice Bilgic; FernandaM Shoyama; DavidO Schmeling; HenryH Balfour; Kiminori Hasegawa; AndrewC Chan; JohnA Corbett; BryceA Binstadt; MatthewF Mescher; Klaus Ley; Nunzio Bottini; ErikJ Peterson

doi:10.1016/j.immuni.2013.06.013

The Autoimmunity-Associated Gene PTPN22 Potentiates Toll-like Receptor-Driven, Type 1 Interferon-Dependent Immunity

Yaya Wang, Iftach Shaked, StephanieM Stanford, Wenbo Zhou, JulieM Curtsinger, Zbigniew Mikulski, ZacharyR Shaheen, Genhong Cheng, Kristy Sawatzke, AmandaM Campbell, JenniferL Auger, Hatice Bilgic, FernandaM Shoyama, DavidO Schmeling, HenryH Balfour, Kiminori Hasegawa, AndrewC Chan, JohnA Corbett, BryceA Binstadt, MatthewF MescherKlaus Ley, Nunzio Bottini, ErikJ Peterson

Research output: Contribution to journal › Article › peer-review

154 Scopus citations

Abstract

Immune cells sense microbial products through Toll-like receptors (TLR), which trigger host defense responses including type 1 interferons (IFNs) secretion. A coding polymorphism in the protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene is a susceptibility allele for human autoimmune and infectious disease. We report that Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells. Ptpn22 promoted host antiviral responses and was critical for TLR agonist-induced, type 1 IFN-dependent suppression of inflammation in colitis and arthritis. PTPN22 directly associated with TNF receptor-associated factor 3 (TRAF3) and promotes TRAF3 lysine 63-linked ubiquitination. The disease-associated PTPN22W variant failed to promote TRAF3 ubiquitination, type 1 IFN upregulation, and type 1 IFN-dependent suppression of arthritis. The findings establish a candidate innate immune mechanism of action for a human autoimmunity "risk" gene in the regulation of host defense and inflammation.

Original language	English (US)
Pages (from-to)	111-122
Number of pages	12
Journal	Immunity
Volume	39
Issue number	1
DOIs	https://doi.org/10.1016/j.immuni.2013.06.013
State	Published - Jul 25 2013

Bibliographical note

Funding Information:
We thank G. Koretzky (University of Pennsylvania) for critical reading of the manuscript, the S. Fahrenkrug laboratory and Mouse Genetics Laboratory (University of Minnesota, UMN) for assistance with generation of transgenic mice, and Z. Zhang (Indiana University) for providing PTPN22 inhibitors. The D. Masopust (UMN) and M. von Herrath (LIAI) laboratories assisted with viral infection protocols. M. Jenkins (UMN) provided reagents. J. Gonzalez-Navajas (LIAI) provided technical assistance with ubiquitination assays. S. DuCloux-Potter provided secretarial assistance. This work was supported by grants from the National Institutes of Health (NIH) R01AR057781, the American College of Rheumatology Within Our Reach Campaign, the American Diabetes Association, the Alliance for Lupus Research, and Lupus Foundation of Minnesota (to E.J.P.), the International Center for Antiviral Research and Epidemiology, UMN (to H.H.B.), and NIH R01AI070544 (to N.B.). S.M.S was supported by a postdoctoral fellowship from the Juvenile Diabetes Research Foundation. A.C.C. is an employee of Genentech. This is the publication #1622 from the La Jolla Institute for Allergy and Immunology.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.immuni.2013.06.013

OpenUrl availability

Full text

Cite this

Wang, Y., Shaked, I., Stanford, S., Zhou, W., Curtsinger, J., Mikulski, Z., Shaheen, Z., Cheng, G., Sawatzke, K., Campbell, A., Auger, J., Bilgic, H., Shoyama, F., Schmeling, D., Balfour, H., Hasegawa, K., Chan, A., Corbett, J., Binstadt, B., ... Peterson, E. (2013). The Autoimmunity-Associated Gene PTPN22 Potentiates Toll-like Receptor-Driven, Type 1 Interferon-Dependent Immunity. Immunity, 39(1), 111-122. https://doi.org/10.1016/j.immuni.2013.06.013

Wang, Y, Shaked, I, Stanford, S, Zhou, W, Curtsinger, J, Mikulski, Z, Shaheen, Z, Cheng, G, Sawatzke, K, Campbell, A, Auger, J, Bilgic, H, Shoyama, F, Schmeling, D, Balfour, H, Hasegawa, K, Chan, A, Corbett, J, Binstadt, B, Mescher, M, Ley, K, Bottini, N & Peterson, E 2013, 'The Autoimmunity-Associated Gene PTPN22 Potentiates Toll-like Receptor-Driven, Type 1 Interferon-Dependent Immunity', Immunity, vol. 39, no. 1, pp. 111-122. https://doi.org/10.1016/j.immuni.2013.06.013

@article{d7f5af5e665a49fd87e8995efae78906,

title = "The Autoimmunity-Associated Gene PTPN22 Potentiates Toll-like Receptor-Driven, Type 1 Interferon-Dependent Immunity",

abstract = "Immune cells sense microbial products through Toll-like receptors (TLR), which trigger host defense responses including type 1 interferons (IFNs) secretion. A coding polymorphism in the protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene is a susceptibility allele for human autoimmune and infectious disease. We report that Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells. Ptpn22 promoted host antiviral responses and was critical for TLR agonist-induced, type 1 IFN-dependent suppression of inflammation in colitis and arthritis. PTPN22 directly associated with TNF receptor-associated factor 3 (TRAF3) and promotes TRAF3 lysine 63-linked ubiquitination. The disease-associated PTPN22W variant failed to promote TRAF3 ubiquitination, type 1 IFN upregulation, and type 1 IFN-dependent suppression of arthritis. The findings establish a candidate innate immune mechanism of action for a human autoimmunity {"}risk{"} gene in the regulation of host defense and inflammation.",

author = "Yaya Wang and Iftach Shaked and StephanieM Stanford and Wenbo Zhou and JulieM Curtsinger and Zbigniew Mikulski and ZacharyR Shaheen and Genhong Cheng and Kristy Sawatzke and AmandaM Campbell and JenniferL Auger and Hatice Bilgic and FernandaM Shoyama and DavidO Schmeling and HenryH Balfour and Kiminori Hasegawa and AndrewC Chan and JohnA Corbett and BryceA Binstadt and MatthewF Mescher and Klaus Ley and Nunzio Bottini and ErikJ Peterson",

note = "Funding Information: We thank G. Koretzky (University of Pennsylvania) for critical reading of the manuscript, the S. Fahrenkrug laboratory and Mouse Genetics Laboratory (University of Minnesota, UMN) for assistance with generation of transgenic mice, and Z. Zhang (Indiana University) for providing PTPN22 inhibitors. The D. Masopust (UMN) and M. von Herrath (LIAI) laboratories assisted with viral infection protocols. M. Jenkins (UMN) provided reagents. J. Gonzalez-Navajas (LIAI) provided technical assistance with ubiquitination assays. S. DuCloux-Potter provided secretarial assistance. This work was supported by grants from the National Institutes of Health (NIH) R01AR057781, the American College of Rheumatology Within Our Reach Campaign, the American Diabetes Association, the Alliance for Lupus Research, and Lupus Foundation of Minnesota (to E.J.P.), the International Center for Antiviral Research and Epidemiology, UMN (to H.H.B.), and NIH R01AI070544 (to N.B.). S.M.S was supported by a postdoctoral fellowship from the Juvenile Diabetes Research Foundation. A.C.C. is an employee of Genentech. This is the publication #1622 from the La Jolla Institute for Allergy and Immunology. ",

year = "2013",

month = jul,

day = "25",

doi = "10.1016/j.immuni.2013.06.013",

language = "English (US)",

volume = "39",

pages = "111--122",

journal = "Immunity",

issn = "1074-7613",

publisher = "Cell Press",

number = "1",

}

TY - JOUR

T1 - The Autoimmunity-Associated Gene PTPN22 Potentiates Toll-like Receptor-Driven, Type 1 Interferon-Dependent Immunity

AU - Wang, Yaya

AU - Shaked, Iftach

AU - Stanford, StephanieM

AU - Zhou, Wenbo

AU - Curtsinger, JulieM

AU - Mikulski, Zbigniew

AU - Shaheen, ZacharyR

AU - Cheng, Genhong

AU - Sawatzke, Kristy

AU - Campbell, AmandaM

AU - Auger, JenniferL

AU - Bilgic, Hatice

AU - Shoyama, FernandaM

AU - Schmeling, DavidO

AU - Balfour, HenryH

AU - Hasegawa, Kiminori

AU - Chan, AndrewC

AU - Corbett, JohnA

AU - Binstadt, BryceA

AU - Mescher, MatthewF

AU - Ley, Klaus

AU - Bottini, Nunzio

AU - Peterson, ErikJ

N1 - Funding Information: We thank G. Koretzky (University of Pennsylvania) for critical reading of the manuscript, the S. Fahrenkrug laboratory and Mouse Genetics Laboratory (University of Minnesota, UMN) for assistance with generation of transgenic mice, and Z. Zhang (Indiana University) for providing PTPN22 inhibitors. The D. Masopust (UMN) and M. von Herrath (LIAI) laboratories assisted with viral infection protocols. M. Jenkins (UMN) provided reagents. J. Gonzalez-Navajas (LIAI) provided technical assistance with ubiquitination assays. S. DuCloux-Potter provided secretarial assistance. This work was supported by grants from the National Institutes of Health (NIH) R01AR057781, the American College of Rheumatology Within Our Reach Campaign, the American Diabetes Association, the Alliance for Lupus Research, and Lupus Foundation of Minnesota (to E.J.P.), the International Center for Antiviral Research and Epidemiology, UMN (to H.H.B.), and NIH R01AI070544 (to N.B.). S.M.S was supported by a postdoctoral fellowship from the Juvenile Diabetes Research Foundation. A.C.C. is an employee of Genentech. This is the publication #1622 from the La Jolla Institute for Allergy and Immunology.

PY - 2013/7/25

Y1 - 2013/7/25

N2 - Immune cells sense microbial products through Toll-like receptors (TLR), which trigger host defense responses including type 1 interferons (IFNs) secretion. A coding polymorphism in the protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene is a susceptibility allele for human autoimmune and infectious disease. We report that Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells. Ptpn22 promoted host antiviral responses and was critical for TLR agonist-induced, type 1 IFN-dependent suppression of inflammation in colitis and arthritis. PTPN22 directly associated with TNF receptor-associated factor 3 (TRAF3) and promotes TRAF3 lysine 63-linked ubiquitination. The disease-associated PTPN22W variant failed to promote TRAF3 ubiquitination, type 1 IFN upregulation, and type 1 IFN-dependent suppression of arthritis. The findings establish a candidate innate immune mechanism of action for a human autoimmunity "risk" gene in the regulation of host defense and inflammation.

AB - Immune cells sense microbial products through Toll-like receptors (TLR), which trigger host defense responses including type 1 interferons (IFNs) secretion. A coding polymorphism in the protein tyrosine phosphatase nonreceptor type 22 (PTPN22) gene is a susceptibility allele for human autoimmune and infectious disease. We report that Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells. Ptpn22 promoted host antiviral responses and was critical for TLR agonist-induced, type 1 IFN-dependent suppression of inflammation in colitis and arthritis. PTPN22 directly associated with TNF receptor-associated factor 3 (TRAF3) and promotes TRAF3 lysine 63-linked ubiquitination. The disease-associated PTPN22W variant failed to promote TRAF3 ubiquitination, type 1 IFN upregulation, and type 1 IFN-dependent suppression of arthritis. The findings establish a candidate innate immune mechanism of action for a human autoimmunity "risk" gene in the regulation of host defense and inflammation.

UR - http://www.scopus.com/inward/record.url?scp=84880733694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880733694&partnerID=8YFLogxK

U2 - 10.1016/j.immuni.2013.06.013

DO - 10.1016/j.immuni.2013.06.013

M3 - Article

C2 - 23871208

AN - SCOPUS:84880733694

SN - 1074-7613

VL - 39

SP - 111

EP - 122

JO - Immunity

JF - Immunity

IS - 1

ER -

The Autoimmunity-Associated Gene PTPN22 Potentiates Toll-like Receptor-Driven, Type 1 Interferon-Dependent Immunity

Abstract

Bibliographical note

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this